Joseph B. Shrager

Active 1991–2025

92
Papers
19,385
Citations
61
h-index
86
i10-index

Citations

Citations per year for Joseph B. Shrager1990: 1 citations1993: 17 citations1994: 8 citations1995: 18 citations1996: 14 citations1997: 22 citations1998: 33 citations1999: 20 citations2000: 28 citations2001: 31 citations2002: 46 citations2003: 35 citations2004: 51 citations2005: 52 citations2006: 52 citations2007: 25 citations2008: 60 citations2009: 69 citations2010: 67 citations2011: 60 citations2012: 64 citations2013: 82 citations2014: 101 citations2015: 126 citations2016: 174 citations2017: 208 citations2018: 264 citations2019: 667 citations2020: 833 citations2021: 793 citations2022: 705 citations2023: 528 citations2024: 732 citations2025: 431 citations2026: 25 citations1991–1992: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,497 citing papers, 28% of this breakdownChina: 1,070 citing papers, 12% of this breakdownUnited Kingdom: 555 citing papers, 6.2% of this breakdownItaly: 456 citing papers, 5.1% of this breakdownCanada: 437 citing papers, 4.9% of this breakdownFrance: 397 citing papers, 4.4% of this breakdownGermany: 386 citing papers, 4.3% of this breakdownJapan: 273 citing papers, 3.1% of this breakdownAustralia: 260 citing papers, 2.9% of this breakdownNetherlands: 257 citing papers, 2.9% of this breakdownSpain: 238 citing papers, 2.7% of this breakdownSwitzerland: 204 citing papers, 2.3% of this breakdown
0%28%Other 21.2%

Fields

  • Biochemistry, Genetics and Molecular Biology48%
  • Medicine46.1%
  • Engineering1.4%
  • Immunology and Microbiology1.3%
  • Computer Science1.1%
  • Neuroscience0.8%
  • Other1.3%

Topics

  • Cancer Genomics and Diagnostics9.2%
  • Muscle Physiology and Disorders6.3%
  • Lung Cancer Treatments and Mutations4.5%
  • Lung Cancer Diagnosis and Treatment3.4%
  • Radiomics and Machine Learning in Medical Imaging2.8%
  • Cancer Cells and Metastasis2.5%
  • Other71.3%

Coauthors

All papers

Open in search
  1. An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage

    Authors: , , , , , , , , , , , , , - Nature Medicine 2014 cited by 2,252

  2. Integrating genomic features for non-invasive early lung cancer detection

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Robert Tibshirani, Sanjiv S. Gambhir, Gerald J. Berry, Kristin C. Jensen, Robert B. West, Joel W. Neal, Heather A. Wakelee, Billy W. Loo, Christian A. Kunder, Ann N. Leung, Natalie S. Lui, Mark F. Berry, Joseph B. Shrager, Viswam S. Nair, Daniel A. Haber, Lecia V. Sequist, Ash A. Alizadeh, Maximilian Diehn - Nature 2020 cited by 703

  3. Early Detection of Molecular Residual Disease in Localized Lung Cancer by Circulating Tumor DNA Profiling

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Discovery 2017 cited by 1,078

  4. Integrated digital error suppression for improved detection of circulating tumor DNA

    Authors: , , , , , , , , , , , , , , , , , , , - Nature Biotechnology 2016 cited by 1,144

  5. A radiogenomic dataset of non-small cell lung cancer

    Authors: , , , , , , , , , , , , , , , , - Scientific Data 2018 cited by 315

  6. Rapid Disuse Atrophy of Diaphragm Fibers in Mechanically Ventilated Humans

    Authors: , , , , , , , , , , , , - New England Journal of Medicine 2008 cited by 1,565

  7. Bioengineered constructs combined with exercise enhance stem cell-mediated treatment of volumetric muscle loss

    Authors: , , , , , , , , , , - Nature Communications 2017 cited by 284

  8. p53 governs an AT1 differentiation programme in lung cancer suppression

    Authors: , , , , , , , , , , , , , , , , - Nature 2023 cited by 91

  9. A molecular cell atlas of the human lung from single cell RNA sequencing

    Authors: , , , , , , , , , , , , , , , , , - Nature 2019 cited by 1,872

  10. KEAP1/NFE2L2 Mutations Predict Lung Cancer Radiation Resistance That Can Be Targeted by Glutaminase Inhibition

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Maximilian Diehn - Cancer Discovery 2020 cited by 173

  11. Global analysis of shared T cell specificities in human non-small cell lung cancer enables HLA inference and antigen discovery

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Steven A. Feldman, Maximilian Diehn, Irving L. Weissman, Jianjun Zhang, Ignacio I. Wistuba, P. Andrew Futreal, John V. Heymach, K. Christopher García, Crystal L. Mackall, Mark M. Davis - Immunity 2021 cited by 136

  12. Dystrophin protects the sarcolemma from stresses developed during muscle contraction.

    Authors: , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 1993 cited by 1,516

  13. mTORC1 underlies age‐related muscle fiber damage and loss by inducing oxidative stress and catabolism

    Authors: , , , , , , , , , , , , , , , , , , , , - Aging Cell 2019 cited by 184

  14. The mdx mouse diaphragm reproduces the degenerative changes of Duchenne muscular dystrophy

    Authors: , , , , , , , , , - Nature 1991 cited by 922

  15. Non–Small Cell Lung Cancer Radiogenomics Map Identifies Relationships between Molecular and Imaging Phenotypes with Prognostic Implications

    Authors: , , , , , , , , , , - Radiology 2017 cited by 193

  16. GFPT2 -Expressing Cancer-Associated Fibroblasts Mediate Metabolic Reprogramming in Human Lung Adenocarcinoma

    Authors: , , , , , , , , , , , , , , , - Cancer Research 2018 cited by 119

  17. Interstitial macrophages are a focus of viral takeover and inflammation in COVID-19 initiation in human lung

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - The Journal of Experimental Medicine 2024 cited by 46

  18. Ex Vivo Expansion and In Vivo Self-Renewal of Human Muscle Stem Cells

    Authors: , , , , , , - Stem Cell Reports 2015 cited by 205

  19. KRAS(G12D) drives lepidic adenocarcinoma through stem-cell reprogramming

    Authors: , , , , , , , , , , - Nature 2023 cited by 40

  20. Impact of KRAS mutation subtype and concurrent pathogenic mutations on non-small cell lung cancer outcomes

    Authors: , , , , , , - Lung Cancer 2019 cited by 130

  21. Cross-Species Functional Analysis of Cancer-Associated Fibroblasts Identifies a Critical Role for CLCF1 and IL-6 in Non–Small Cell Lung Cancer In Vivo

    Authors: , , , , , , , , , , , , , , - Cancer Research 2012 cited by 126

  22. Determinants of Complete Resection of Thymoma by Minimally Invasive and Open Thymectomy: Analysis of an International Registry

    Authors: , , , , , , , , , - Journal of Thoracic Oncology 2016 cited by 102

  23. A national analysis of open versus minimally invasive thymectomy for stage I to III thymoma

    Authors: , , , , , , , , , - Journal of Thoracic and Cardiovascular Surgery 2019 cited by 85

  24. Antitumor activity of an engineered decoy receptor targeting CLCF1–CNTFR signaling in lung adenocarcinoma

    Authors: , , , , , , , , , , , , , , , - Nature Medicine 2019 cited by 79